4893 items matching your search terms.

Long-term quality of life (QoL) following prostate irradiation: relationship to anorectal symptoms employing a proctitis-specific QoL instrument

Turner, S Kneebone, A Bolin, T Spry, N Gebski, V

Prognostic factors of toxicity and efficacy in patients with gastro-intestinal stromal tumors treated with imatinib: a study of the EORTC-STBSG, ISG and AGITG

Van Glabbeke, MM Verweij, J Casali, PG Zalcberg, J Le Cesne, A Reichard, P Blay, JY Schlemmer, M Donato Di Paola, E Judson, IR

Anterior tongue cancer: age is not a predictor of outcome and should not alter treatment

Veness, MJ Morgan, GJ Sathiyaseelan, Y Gebski, V

Cutaneous head and neck squamous cell carcinoma metastatic to cervical lymph nodes (nonparotid): a better outcome with surgery and adjuvant radiotherapy

Veness, MJ Palme, CE Smith, M Cakir, B Morgan, GJ Kalnins, I

Anterior tongue cancer: age is not a predictor of outcome and should not alter treatment

Veness, M. J. Morgan, G. J. Sathiyaseelan, Y. Gebski, V.

Early efficacy comparison of two doses of imatinib for the treatment of advanced gastrointestinal stromal tumors: Interim results of a randomized phase III trial from the EORTC-STBSG, ISG and AGITG

Verweij, J Casali, PG Zalcberg, J Le Cesne, A Reichard, P Blay, JY Issels, RD Van Glabbeke, M Donato Di Paola, E Judson, IR

Impaired creatinine clearance is a risk factor for cardiovascular outcomes in patients with coronary heart disease and pravastatin reduces events similarly in patients with high and low creatinine clearance levels: results from the LIPID study

West, M; Hargreaves, C; Kirby, A; Simes, J; Tonkin, A; Colquhoun, D

Eligibility and choice in the Royal Australasian College of Surgeons SNAC trial of sentinel node biopsy vs axillary clearance in operable breast cancer

Wetzig, NR Gill, PG Ung, O Collins, J Kollias, J Gillette, D Gebski, V Coskinas, X Cakir, B Stockler, M

Fulvestrant: spreading the word, but not too thinly

Wilcken, NR Stockler, MR
LANCET, 2003     DOI:10.1016/s0140-6736(03)14616-8

Determining the sample size in a clinical trial (multiple letters)

Williamson, O. D. Kirby, A. Gebski, V. Keech, A. C.

South East London Cancer Research Network and clinical trials: a UK experience

Yip, SS Harper, PG

Early efficacy comparison of two doses of imatinib for the treatment of advanced gastro-intestinal stromal tumors: interim results of a randomized phase II trial from EORTC-STBSG, ISG & AGITG

Zalcberg, J Verweij, J Casali, PG Le Cesne, A Reichardt, P Blay, JY Issels, RD Van Glabbeke, M Donato di Paola, E Judson, IR Dhillon, H Kotasek, D Findlay, M Goldstein, D

Sustained ventricular arrhythmias among patients with acute coronary syndromes with no ST-segment elevation: incidence, predictors, and outcomes

Al-Khatib, SM; Granger, CB; Huang, Y; Lee, KL; Califf, RM; Simoons, ML; Armstrong, PW; Van de Werf, F; White, HD; Simes, RJ; Moliterno, DJ; Topol, EJ; Harrington, RA

Is catheter-based intravascular brachytherapy associated with an increased rate of late thrombosis? A meta-analysis

Barr, E.

Levels of evidence available to inform governmental health technology policy decisions

Barr, E. Belcher, J. Wortley, S.